Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan's Health Ministry Improves Drug Pricing For Innovators

This article was originally published in The Pink Sheet Daily

Executive Summary

Japanese agency creates new anti-cancer drugs division and adds personnel to speed up drug reviews, U. S. Trade Representative reports.

You may also be interested in...

USTR Objects to Japan’s Annual Drug Repricing Plan, Market Expansion Repricing

Japan’s MHLW Steps Up Efforts To Reduce Drug Approval Lag Time

TOKYO - On the back of rising pressures, Japan's Ministry of Health, Labor and Welfare is stepping up efforts to shorten new drug approval periods that now are woefully behind other countries - yet finds the undertaking a tall task that may take longer than officials envisioned

Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says

Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts